NF-κB and AP-1 as molecular targets for chemoprevention with EGCG, a review

Environmental Chemistry Letters

Volumn 4, Issue 3, 2006, Pages 137-141

  Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

AP 1; Chemoprevention; EGCG; Green tea; NF kappaB; Signal transduction

Indexed keywords

EID: 33746534907     PISSN: 16103653     EISSN: 16103661     Source Type: Journal    
DOI: 10.1007/s10311-006-0063-0     Document Type: Review

References (30)

1. Afaq F, Adhami VM, Ahmad N, Mukhtar H (2003) Inhibition of ultraviolet B-mediated activation of nuclear factor κB in normal human epidermal keratinocytes by green tea Constituent (-) -epigallocatechin-3-gallate. Oncogene 22:1035-1044
2. Barthelman M, Bair WB III, Stickland KK, Chen W, Timmermann BN, Valcic S, Dong Z, Bowden GT (1998) (-) -Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis 19:2201-2204
3. Bode AM, Dong Z (2003) Signal transduction pathways: Targets for green and black tea polyphenols. J Biochem Mol Biol 36:66-77
4. Bode AM, Dong Z (2004) Targeting signal transduction pathways by chemopreventive agents. Mutat Res 555:33-51
5. Chen F, Castranova V, Shi X (2001) New insights into the role of nuclear factor-κB in cell growth regulation. Am J Pathol 159:387-397
6. Chen W, Bowden GT (2000) Role of p38 mitogen-activated protein kinases in ultraviolet-B irradiation-induced activator protein 1 activation in human keratinocytes. Mol Carcinog 28:196-202
7. Dong Z (2000) Effects of food factors on signal transduction pathways. Biofactors 12:17-28
8. Dorai T, Aggarwal BB (2004) Role of chemopreventive agents in cancer therapy. Cancer Lett 215:129-140
9. Fujiki H, Suganuma M, Okabe S, Sueoka E, Sueoka N, Fujimoto N, Goto Y, Matsuyama S, Imai K, Nakachi K (2001) Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat Res 480-481:299-304
10. Greten FR, Karin M (2004) The IKK/NF-kappaB activation pathway - a target for prevention and treatment of cancer. Cancer Lett 206:193-199
11. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H (2004) Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappaB and induction of apoptosis. Oncogene 23:2507-2522
12. Karin M (1999) How NF-κB is activated: The role of the IκB kinase (IKK) complex. Oncogene 18:6867-6874
13. Kim HS, Kim MH, Jeong M, Hwang YS, Lim SH, Shin BA, Ahn BW, Jung YD (2004) EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res 24:747-753
14. Kundu JK, Na H-K, Chun K-S, Kim Y-K, Lee SJ, Lee SS, Lee OS, Sim Y-C, Surh Y-J (2003) Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J Nutr 133:3805S-3810S
15. Masuda M, Suzui M, Lim JTE, Deguchi A, Soh J-W, Weinstein IB (2002) Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2:350-359
16. Mukhtar H, Ahmad N (1999) Mechanism of cancer chemopreventive activity of green tea. Proc Soc Exp Biol Med 220:234-238
17. Nomura M, Kaji A, He Z, Ma W-Y, Miyamoto K-I, Yang CS, Dong Z (2001) Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 276:46624-46631
18. Nomura M, Ma W-Y, Chen N, Bode AM, Dong Z (2000) Inhibition of 12- O -tetradecanoylphorbol-13-acetate-induced NF-κB activation by tea polyphenols, (-) -epigallocatechin gallate and theaflavins. Carcinogenesis 21:1885-1890
19. Park OJ, Surh Y-J (2004) Chemopreventive potential of epigallocatechin gallate and genistein: Evidence from epidemiological and laboratory studies. Toxicol Lett 150:43-56
20. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136
21. Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20:2390-2400
22. Suganuma M, Okabe S, Sueoka N, Sueoka E, Matsuyama S, Imai K, Nakachi K, Fujiki H (1999) Green tea and cancer chemoprevention. Mutat Res 428:339-344
23. Surh Y-J (1999) Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 428:305-327
24. Surh Y-J (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768-780
25. Vayalil PK, Katiyar SK (2004) Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-B in human prostate carcinoma DU-145 cells. Prostate 59:33-42
26. Wang SI, Mukhtar H (2002) Gene expression profile in human prostate LNCaP cancer cells by (-) epigallocatechin-3-gallate. Cancer Lett 182:43-51
27. Weinreb O, Mandel S, Youdim MBH (2003) cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. FASEB J 17:935-937
28. Yang CS (1997) Inhibition of carcinogenesis by tea. Nat (London) 389:134-135
29. Yang CS, Chung JY, Yang GY, Li C, Meng X, Lee MJ (2000) Mechanisms of inhibition of carcinogenesis by tea. Biofactors 13:73-79
30. Yang F, Oz HS, Barve S, de Villiers WJ, McClain CJ, Varilek GW (2001) The green tea polyphenol (-) -epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 60:528-533